Patrick Campbell

A new study from Brigham and Women's Hospital found a home hospital model of care reduced cost while maintaining standards of care compared to typical in-hospital care.

In March 2020, the therapy has the potential to become the first approved for the rare autoimmune disorder.

A research letter published in JAMA Network Open is painting a clearer picture of how the introduction of a biosimilar impacts trends in pricing, cost, and discounts related to the originator biologic.

The FDA has granted marketing authorization for the GSP Neonatal Creatine Kinase-MM to aid physicians in screening newborns for Duchenne Muscular Dystrophy.

A meta-analysis of more than 1 million patients and 2 dozen studies has revealed patients over 60 with hypothyroidism were at a 26% greater chance of all-cause mortality.

An analysis of the Dongfeng-Tongi cohort has revealed sleeping more than 9 hours per night or taking midday naps lasting longer than 90 minutes was associated with an increase in risk of total stroke.

A study from SUNY University at Buffalo has found adherence to a Western diet could contribute to the development of late age-related macular degeneration.

A new study of more than 60,000 individuals over the course of a decade suggests non-Hispanic blacks were less likely to use and see benefits from low-dose aspirin in the same way as non-Hispanic whites.

Results of a phase 3 study presented during the late-breaking sessions at ASH 2019 has found CC-486 provided patients with significant and meaningful improvements in overall survival (OS) and relapse-free survival.

Results of a phase 3 study presented at ASH 2019 are suggesting blinatumomab was more effective than chemotherapy as a post-reinduction therapy in high and intermediate risk first relapse of b-acute lymphoblastic leukemia.

Results of an interim analysis of a phase 2 trial are suggesting enasidenib plus azacitidine may be more effective than azacitidine monotherapy alone.

An updated meta-analysis from ASH 2019 is detailing the apparent risk of atrial fibrillation and major bleeding associated with ibrutinib use in patients with hematologic malignancies.

How technology, innovation, and preventive care drove the last 10 years of improved public heart health.

A new study presented at ASH 2019 is providing further evidence for the use of weight-adjusted rivaroxaban in children with venous thromboembolism.

A recent study from Penn Medicine presented at ASH 2019 has found mosunetuzumab could be an effective treatment for B-cell non-Hodgkin lymphoma refractory to CAR T therapy.

A new analysis has found the switch to the “increased-risk” donor classification by the US Public Health Service has had minimal impact on outcomes of lung transplants.

An analysis of more than 4 million patients in the Swedish Birth Registry is shining light on the associations between preterm birth and the development of diabetes as a child or young adult.

Results of a pilot study examining the impact of a 10-hour restricted eating window in patients with metabolic syndrome indicate the dietary intervention could help patients lose weight and improve their symptoms without changes in physical activity

An analysis of more than 4 million people from Europe has found children born to mothers with diabetes were at a 29% increased risk of developing cardiovascular disease before the age of 40.

An analysis from the University of Michigan has found postoperative myocardial infarction is still associated with an increased risk of mortality, despite use of evidence-based strategies.

A study presented at EuroEcho 2019 is revealing the ability of ACE inhibitors, ARBs and beta-blockers for the prevention of cardiotoxicity in patients with breast or hematological cancer.

A new analysis is painting a clearer picture of the impact and causes of the rise and fall of US life expectancy between 1959 and 2017.

Results of a recent study have found ice baths, also known as cold water immersion, could actually have a negative impact on repairing and building muscle.

A new 30,000-person review found low lymphocyte cell counts could be an indicator a patient is at an increased risk of all-cause mortality, including death from cardiovascular disease and cancer.

A discussion on why heart failure rates have climbed over the past decade while research indicates rates of cardiovascular disease, as a whole, have begun to decline.

One-year results of the ENLIGHTEN trial are revealing more about the impact of exercise and nutrition on the cognitive health of older patients.

Discussing the key differences in the results of ISCHEMIA and ISCHEMIA-CKD, which examined whether the use of invasive or conservative strategies was more effective for patients with ischemic heart disease.

Results of the ESETT trial are revealing there is little difference in the effectiveness or safety profiles of three anti-seizure treatments for patients with a severe form epilepsy.

Discussing why initiatives and policy changes in the fight against obesity and diabetes have been perceived as less successful than those against smoking and educating on cardiovascular diseases.

Evaluating the impact of DAPA-HF and other recent data that have changed the way cardiologists view the potential uses of SGLT2 inhibitors in patients with or without diabetes.